RNA sequencing can contribute to the development of a reliable drug recommendation tool

October 12, 2018 Leave a comment 2,252 Views

A new precision medicine platform utilizing both DNA and RNA sequencing helps identify targeted therapy options for patients with relapsed or refractory multiple myeloma. Multiple myeloma (MM) is a malignancy of plasma cells, with a median survival...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Icahn School of Medicine Mount Sinai

RNA sequencing can contribute to the development of a reliable drug recommendation tool

Exogene – A performant workflow for detecting viral integrations from paired-end next-generation sequencing data

RNALocate v2.0 – an updated resource for RNA subcellular localization with increased coverage and annotation

A precision oncology framework to predict patient response to cancer therapy from the tumor transcriptome

A comparison of DNA and RNA sequencing of total nucleic acids for metagenomics

New software unveils the relationships between RNA modifications and cancers

Postdoc Position Available – Neurosurgery

Transcriptomic entropy – a biologically relevant and interpretable metric for quantifying PSC-derived tissue maturation